1. Home
  2. STAA vs GRDN Comparison

STAA vs GRDN Comparison

Compare STAA & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • GRDN
  • Stock Information
  • Founded
  • STAA 1982
  • GRDN 2004
  • Country
  • STAA United States
  • GRDN United States
  • Employees
  • STAA N/A
  • GRDN N/A
  • Industry
  • STAA Ophthalmic Goods
  • GRDN Retail-Drug Stores and Proprietary Stores
  • Sector
  • STAA Health Care
  • GRDN Consumer Staples
  • Exchange
  • STAA Nasdaq
  • GRDN Nasdaq
  • Market Cap
  • STAA 1.3B
  • GRDN 1.4B
  • IPO Year
  • STAA N/A
  • GRDN 2024
  • Fundamental
  • Price
  • STAA $24.82
  • GRDN $21.38
  • Analyst Decision
  • STAA Buy
  • GRDN Strong Buy
  • Analyst Count
  • STAA 7
  • GRDN 2
  • Target Price
  • STAA $42.83
  • GRDN $22.50
  • AVG Volume (30 Days)
  • STAA 615.8K
  • GRDN 262.3K
  • Earning Date
  • STAA 10-30-2024
  • GRDN 02-15-2025
  • Dividend Yield
  • STAA N/A
  • GRDN N/A
  • EPS Growth
  • STAA 9.97
  • GRDN N/A
  • EPS
  • STAA 0.44
  • GRDN N/A
  • Revenue
  • STAA $341,224,000.00
  • GRDN $1,170,907,000.00
  • Revenue This Year
  • STAA $8.37
  • GRDN $18.05
  • Revenue Next Year
  • STAA $11.70
  • GRDN $9.55
  • P/E Ratio
  • STAA $56.42
  • GRDN N/A
  • Revenue Growth
  • STAA 10.01
  • GRDN 16.86
  • 52 Week Low
  • STAA $23.72
  • GRDN $14.16
  • 52 Week High
  • STAA $52.68
  • GRDN $25.74
  • Technical
  • Relative Strength Index (RSI)
  • STAA 41.27
  • GRDN N/A
  • Support Level
  • STAA $23.90
  • GRDN N/A
  • Resistance Level
  • STAA $25.77
  • GRDN N/A
  • Average True Range (ATR)
  • STAA 1.45
  • GRDN 0.00
  • MACD
  • STAA 0.01
  • GRDN 0.00
  • Stochastic Oscillator
  • STAA 27.23
  • GRDN 0.00

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.

Share on Social Networks: